ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.19
-1.33%
US Tech 100
20,591.20
-1.49%
S&P 500
5,906.94
-1.07%
US Dollar vs CAD
1.43505
0.00%
Bitcoin
92,450.98
-0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Panacea Acquisition Corp (NUVB) Share Price

Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

NYSE
2.62
-0.14
(-5.07%)
Closed December 30 3:00PM
Delayed by 15 minutes
2.6201
0.0001
(0.00%)
After Hours: 5:34PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.6201
Bid
-
Ask
-
Volume
927,361
2.61 Day's Range 2.705
1.43 52 Week Range 4.1598
Market Cap
881.838M
Previous Close
2.76
Open
2.69
Last Trade
116115
@
2.62
Last Trade Time
Financial Volume
US$ 2,451,477
VWAP
2.6435
Average Volume (3m)
2,194,691
Shares Outstanding
336,566,525
Dividend Yield
-
PE Ratio
-11.59
Earnings Per Share (EPS)
-0.23
Revenue
-
Net Profit
-75.8M

About Panacea Acquisition Corp

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
ecor1cap.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker NUVB. The last closing price for Panacea Acquisition was US$2.76. Over the last year, Panacea Acquisition shares have traded in a share price range of US$ 1.43 to US$ 4.1598.

Panacea Acquisition currently has 336,566,525 shares outstanding. The market capitalization of Panacea Acquisition is US$928.92 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -11.59.

Ask ADVFN Intelligence (AI)

NUVB Latest News

More News

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

New Drug Application (NDA) is based on pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies of taletrectinib that demonstrated durable responses and prolonged progression-free...

December 23 2024
Business Wire

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

December 20 2024
PR Newswire (US)

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

November 26 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

November 12 2024
Business Wire

Form 8-K - Current report

November 06 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 06 2024
Edgar (US Regulatory)

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Submitted New Drug Application (NDA) for taletrectinib to the U.S. Food and Drug Administration (FDA) in October for the treatment of patients with advanced ROS1-positive (ROS1+) non-small cell...

November 06 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

October 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

October 09 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1999-7.088652482272.822.87992.5714882962.74938089CS
4-0.2899-9.962199312712.913.032.5124460962.73724536CS
120.21018.717842323652.413.08221946912.64013919CS
26-0.3899-12.95348837213.013.97218269042.79830933CS
521.120174.67333333331.54.15981.4315890972.80207322CS
156-5.6899-68.47051744898.318.880.9510829332.7618798CS
260-7.3799-73.7991015.230.9510383994.25182202CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2.6201
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336,566,525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 928.92M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1.43 to US$ 4.1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -11.59
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75.8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VHCVirnetX Holding Corp
US$ 8.89
(69.33%)
478.59k
PERFPerfect Corp
US$ 3.27
(28.24%)
1.25M
STEMStem Inc
US$ 0.7558
(27.11%)
67.14M
AMPXAmprius Technologies Inc
US$ 2.97
(25.85%)
11.52M
BBAIBigBear ai Holdings Inc
US$ 4.825
(14.61%)
76.08M
EVTLVertical Aerospace Ltd
US$ 12.54
(-19.10%)
547.78k
MPLNChurchill Capital Corp III
US$ 14.85
(-15.24%)
259.69k
DNMRDanimer Scientific Inc
US$ 4.06
(-13.98%)
211.63k
EXTOAlmacenes Exito SA
US$ 3.17
(-11.20%)
302.09k
FREYFREYR Battery Inc
US$ 2.70
(-10.89%)
4.4M
BBAIBigBear ai Holdings Inc
US$ 4.825
(14.61%)
76.08M
STEMStem Inc
US$ 0.7558
(27.11%)
67.14M
ABEVAmbev SA
US$ 1.85
(-1.07%)
59.6M
QBTSD Wave Quantum Inc
US$ 9.30
(-6.16%)
57.61M
FFord Motor Company
US$ 9.87
(-1.60%)
47.1M

NUVB Discussion

View Posts
Monksdream Monksdream 4 months ago
NUVB under $4
👍️0
Monksdream Monksdream 5 months ago
NUVB under $3
👍️0
littlefish littlefish 6 months ago
Looks decent, I’ve been building a position around $3 lately.
👍️0
Monksdream Monksdream 8 months ago
NUVB under $5
👍️0
glenn1919 glenn1919 9 months ago
NUVB.............................................https://stockcharts.com/h-sc/ui?s=NUVBB&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 9 months ago
looking strong a/h trading
👍️0
glenn1919 glenn1919 9 months ago
NUVB..............................https://stockcharts.com/h-sc/ui?s=NUVB&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 9 months ago
busting 4 bucks now, weeee!!
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
NUVB...COMING OUT OF A MONTHLY TIGHT BAND...THATS WHY THE MONSTER MOVE!!!
👍️0
gail gail 9 months ago
i must say, i have seen…….

…

you on many stocks you hated, but im relieved to see you like this one. that says something.
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
SUPER THIN....THE POWER OF A WEEKLY BREAK OUT...BULLISH AS FUC
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
NUVB...HERE COMES 4 DOLLA
👍️0
gail gail 9 months ago
it does move well, daily!
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
nuvb...here we go....bio beast
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
NUVB...MONSTA
👍️0
tw0122 tw0122 9 months ago
New price target $10 by Jeffries from $1.40
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
nuvb...big gapper
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
NUVB next bio beast
👍️0
Monksdream Monksdream 9 months ago
NUVB new 52 hi
👍️0
Monksdream Monksdream 10 months ago
NUVB new 52 week high
👍️0
Monksdream Monksdream 10 months ago
NUVB new 52 week high
👍️0

Your Recent History

NYSE
NUVB
Panacea Acquisition
NYSE
AKO.A
Embotelladora Andina
BIT
NSCIT2752813
AIIB
BIT
Q00414
Leonteq Securities
BOV
BRFS3
BRF S/A ON
BIT
CMU
Amundi ETF Msci Emu Esg ...
BOV
VTLT11
Fundo Investimento Imobi...
BOV
USIM3
USIMINAS ON
BOV
JSLG3
JSL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads